Institutional responses to a detailed multi-national survey were used to characterise the range of current anaesthetic and surgical practices for paediatric scoliosis surgery. Questions addressed surgical practice, anaesthetic agents, blood-sparing techniques, neurophysiological monitoring used and recalled major complications. Twenty-seven (87%) institutions responded. The median number of cases of these institutions was 40 per year (range 5 to 700). Common practices included inhaled volatile anaesthetic maintenance (80%), omission of nitrous oxide (81%), intravenous remifentanil (88% [range 0.05 to 2.00 µg.kg -1 .min -1 ]), and double intravenous antiemetic agent prophylaxis (59%); multimodal analgesia with paracetamol and parenteral opioids, non-steroidal antiinflammartory drugs and epidural local anaesthetic or opioid infusion (UK) and intrathecal opioids and subanaesthetic doses of intravenous ketamine by infusion (Australia); use of cell-saver (81%), controlled hypotension (77%) and antifibrinolytic agents (74%) (intravenous aprotinin [59%] or tranexamic acid [44%]); and epidural somatosensory (92%), neurogenic motor-evoked (32%), compound motor action (31%) and transcranial motorevoked potential monitoring (54%), with routine wake-up test used infrequently (19%). Fifty-four neurological or cardiac adverse events or deaths were recalled. While institutional practices varied, common themes were identified. The information obtained may suggest new strategies to various centres and could be useful for planning multi-centre audits and trials.
Anaesthetists' and surgeons' practices in scoliosis surgery have evolved with the availability of new agents and techniques and these differ within institutions and internationally. Through conference and email interchange, discussion arises regarding the superiority of certain techniques, as studies are few and usually focus upon one aspect. The range or frequency of use of the various practices is unknown. A 2003 survey of American anaesthesiologists' practice for spinal surgery was published 1 with a small scoliosis focus (19%) and wide reported anaesthetic practice variation. The same survey identified the frequent use of preoperative autologous donation (84%), cell-saving (87%) and controlled hypotension (CH) (employed with intravenous [IV] sodium nitroprusside, IV labetalol and deepening of inhaled volatile anaesthetic agent) as allogenic bloodsparing techniques. Epidural somatosensory-evoked potentials (SEP, 75%) were used more than motorevoked potentials (MEP, 25%) {type unspecified} as neurophysiological monitoring (NPM). With a low response rate (23%), it did not define anaesthetic agents or adjunctive monitoring used, nor did it distinguish between adult and paediatric scoliosis surgery practices.
We therefore sought information on current paediatric scoliosis anaesthetists' practice, aiming to characterise common practices and variations. Our aim was to conduct a detailed multi-centre, multi-national survey to provide cross-sectional information addressing intraoperative surgical practices and anaesthetic practices regarding anaesthetic agent, monitoring, blood-sparing and NPM techniques and recalled major adverse events.
METHODS
Institutions where paediatric scoliosis surgery is performed were identified in Australia and New Zealand by the Society for Paediatric Anaesthesia in New Zealand and Australia and in the United Kingdom and Republic of Ireland by the Honorary Secretary of the British Scoliosis Society. Each institution's anaesthesia departmental director or secretary identified their scoliosis anaesthetists who were then directly contacted by email/telephone to request their participation and sent a nine-page survey by email/conventional mail in early 2007. This survey was either completed individually or by a lead anaesthetist after discussion with all the institution's scoliosis anaesthetists. Taking approximately 40 minutes to complete, the survey comprised open and closed questions with verbal frequency scales (less than half, about half, more than half and for all patients). The questions addressed various aspects of current anaesthetic/surgical practices including institutional demographics, scoliosis caseload and aetiology, anaesthetic agents, blood-sparing, NPM and intra-and postoperative management techniques. Anaesthetists were asked to document their personal recall of arrests or deaths over a preceding five-year period and neurological events, specifying the time period in which these occurred. Completed surveys were returned by email, fax or conventional mail and return reminders sent at four, eight and 16 weeks. Collected data were entered using Epidata (version 3.1, Denmark: The Epidata Association, 2003 to 2004), amalgamated according to institution and descriptively summarised with Stata Statistical Software (version 9.2, Texas: StataCorp LP, 2006). Where multiple anaesthetists responded from a single institution, their responses were combined to form an overall summary of that institution's practice. Data are presented as frequencies and, when non-normally distributed, as median values and full ranges.
RESULTS
Thirty-one institutions consented to participation: 27 (87%) responded incorporating 57 anaesthetists' replies. The majority were tertiary paediatric centres (63%). Sixteen institutions (59%) had exclusively paediatric patients, one centre had adult patients only and the remainder had a combination of adult and paediatric patients, with only 5% (median) of patients below the age of 10 years (range 0 to 15%). Table 1 shows the estimated median caseload (and range) and percentage of patients with idiopathic aetiology (usually from theatre and/or hospital database enquiry). Non-idiopathic aetiology included congenital scoliosis, neuromuscular disease (cerebral palsy, spina bifida, Duchenne's muscular dystrophy [DMD], spinal muscular atrophy) or associated with Rett's, Angelman's, or Marfan's syndrome or neurofibromatosis. Patients with coexistent cardiac disease, including full to partially repaired tetralogy of Fallot, ventriculoseptal defects and valvular regurgitation, have also received scoliosis surgery.
Overall, a median of one consultant anaesthetist (range 1 to 9) anaesthetises regularly for a median of three consultant orthopaedic scoliosis surgeons (range 1 to 6): generally two consultant surgeons and one surgical trainee operate per case performing anterior releases/instrumentation, combined or posterior instrumentation. Institutions varied as to whether they staged procedures: idiopathic scoliosis patients were usually staged one to two weeks apart and non-idiopathic scoliosis patients usually had combined procedures. Operating frames and tables used in scoliosis surgery varied between institutions and include Acromed (Amsterdam, Holland), Relton-Hall (Toronto, Canada) and Wilson (Union City, CA, USA) frames and standard or specialised posted spinal tables, e.g. Jackson (Union City, CA, USA) and Marquette (Milwaukee, WI, USA). Montreal mattresses, vein boards, head gels, abdominal frame boxes and pillows were used during positioning, depending on the surgical approach and patient size. Eye protection for prone positioning varied between institutions: comprising tape, Tegaderm™ (St. Paul, MN, USA), eye pads and/or head gel supports with 44% also using lubrication. All institutions reported using standard diathermy, with two institutions preferring argon diathermy and one also using the harmonic scalpel for thoracoscopic anterior release procedures. Table 2 lists reported anaesthetic practices. Anxiolytic premedication and anaesthetic maintenance using volatile anaesthetic agents (30% isoflurane, 35% sevoflurane, 35% desflurane) up to 1 MAC are commonly used, with low nitrous oxide use. Volatile agents are used equally by institutions with a caseload of ≤35 patients (25th centile) and those with higher caseloads. Propofol use is routine for 20% of institutions, with an additional 30% using propofol selectively for NPM (see below) or myopathy cases. Various opioids are used, with high frequency of IV remifentanil infusion at varying rates (median: 0.35 µg.kg -1 .minute -1 [range 0.05 to 2.0]) followed by additional intraoperative opioids IV. Some Australian centres use intrathecal morphine (median dose: 5 µg.kg -1 [range 5 to 30]) in contrast to UK/Irish institutions. Double agent intravenous antiemetic prophylaxis is common (59%). An IV induction dose of muscle relaxant is commonly administered, but is continued in the maintenance phase by only one quarter of institutions.
Reported postoperative analgesia ( Table 2) is multimodal; paracetamol combined with opioids by IV infusion or patient-controlled analgesic device was universal.
Step-down opioid choice is highly variable regarding duration (median 14 days [range 5 to 56]) and agent: oral Oxycontin ® /oxycodone, codeine, morphine, methadone, tramadol or transdermal fentanyl patch. Ketamine is used by mostly Australian institutions; 80% using intraoperative IV bolus (median 0.5 mg.kg -1 [range 0.25 to 1.0]) and 80% using intraoperative and/or postoperative IV infusion (median 0.2 mg.kg -1 .hour -1 [range 0.1 to 0.5]). Oral non-steriodal antiinflammatory drugs and epidural catheters (inserted by surgeons, with subsequent epidural local anaesthetic and/or opioid infusion) are used preferentially in the UK/Irish institutions.
Intra-arterial blood pressure monitoring is universal. Central lines are routinely used at 62% of institutions, the remainder with selective use in nonidiopathic or high-risk blood loss scoliosis patients. Transoesophageal echocardiography is used by 19% of institutions (two Australian and three UK), usually for Duchenne's dystrophy patients or those with cardiac lesions. Table 3 lists the blood-sparing techniques utilised. Intraoperative cell-saver, controlled (deliberate or induced) hypotension and IV antifibrinolytic agents are used very frequently and for more than 50% of patients. Antifibrinolytic dosing schedules vary: aprotinin IV via Hammersmith (18%), half Hammersmith (9%) and other dosing protocols (73%: 7500 to 15,000 KIU loading dose, 7500 to 15,000 KIU.hour -1 maintenance) or IV tranexamic acid (TXA) as 10 or 100 mg.kg -1 loading dose with 1 or 10 mg.kg -1 hour -1 .infusion 2 . The reported median intraoperative haemoglobin transfusion trigger is The concurrent use of more than one blood-sparing technique was not addressed by the survey. Table 4 lists the NPM techniques used. All institutions used at least one NPM technique (either SEP or MEP) with 69% using a combination of NPM monitoring. Wake-up tests were not used as standalone monitoring. Ninety-three percent of NPM were interpreted by neurophysiologists and at one centre by an anaesthetist and another by a neurologist. Of those measuring compound motor action potentials {CMAP} (31% of institutions), half use inhaled volatile anaesthetic agents and the remainder total intravenous anaesthesia (TIVA) (with propofol and remifentanil or fentanyl). Fourteen cardiac arrests were recalled and details were specified for four: hyperkalaemia, major haemorrhage and cardiovascular collapse in one patient with cerebral palsy and three DMD patients. Ten deaths were recalled, detail specified for six: three associated with major haemorrhage or transfusion (one DMD in the arrest group and one DMD with transfusion-associated lung injury, one idiopathic scoliosis patient), one acute myocardial infarction in a patient with cardiomyopathy but no other myopathy, one brainstem stroke (with thoracic spina bifida) and one due to sepsis. Closed questions on venous/arterial thrombosis, infection (wound or instrumentation), failed fusion rates, awareness or intraoperative recall during wake-up tests were not included. Table 5 details recalled significant neurological deficits (n=31 from 19 institutions), their nature, if permanent (without causal attribution), the NPM used and whether intraoperative abnormalities occurred and were predictive of postoperative neurological deficit. Motor monitoring (CMAP use and wake-up testing) did not predict three motor deficits; SEP monitoring did not predict four motor deficits. Institutions where CH is and is not used reported cardiac and neurological complications.
Routine postoperative admission to intensive care or high-dependency unit occurs at 73% of institutions. Details of common reasons for intensive care unit admission were not requested. Usual length-of-stay in hospital (reported by 76%) is between seven to 10 days and is longer for posterior and combined procedures.
DISCUSSION
Anaesthetic practice in paediatric scoliosis surgery differs widely, depending on the patient, their scoliosis aetiology, surgical procedure, agent and equipment availability, the institution's aftercare facilities and the anaesthetists' and surgeons' experience and preferences. This survey summarises institutional practice variation and identifies common themes. Only limited comparison with the previous North American survey is possible, as the current survey involves a specific patient subgroup, has a higher response rate and includes additional information.
Regarding anaesthesia maintenance, institutions favour inhalational over a TIVA-propofol technique, as reported previously 1 , and both techniques are used equally for CMAP monitoring, as suggested in the literature 8 . Published comparisons of inhalational and TIVA-propofol techniques demonstrate no differences in recovery time, emergence delirium and postoperative nausea, vomiting or pain 3 . Scoliosis anaesthetists may use IV propofol preferentially, as volatile anaesthetic agents potentially suppress neurophysical signals more (e.g. of epidural SEP amplitude 4 ), induce rhabdomyolysis in dystro-phinopathies 5 or trigger malignant hyperthermia. Interestingly, nitrous oxide use is low. Reasons for non-use were not requested but could include its NPM 6-8 , respiratory, emetic or wound healing effects 9 .
IV remifentanil's widespread use may explain the low nitrous oxide and maintenance IV muscle relaxant use. Several properties make remifentanil appropriate for scoliosis surgery: high potency, volatile anaesthetic agent sparing effect, rapid onset/prompt elimination and allowing flexible intraoperative analgesic control and early recovery 10 . Continuous IV infusion has no effect on neurophysical recordings and provides haemodynamic stability 11 . A negative feature is remifentanil's induction of acute opioid tolerance with higher postoperative opioid requirement 12 . This survey did not pursue opinion or practice regarding this phenomenon, which could be collaboratively addressed in the future.
Perioperative IV ketamine is administered predominantly in Australian institutions, which have similar sub-anaesthetic dosing practices. Potential influences, not explored by the survey, include prevention of remifentanil hyperalgesia 13 , nonsuppression of neurophysical responses 4, 14 and increased adoption of CMAP and transcranial MEP monitoring. Other analgesic practices that vary are the UK non-steriodal anti-inflammatory drugs and epidural infusion use compared with Australian intrathecal opioid preference. Intrathecal morphine doses (2 to 25 µg.kg -1 ) have been studied in scoliosis and lumbar fusion surgery 15, 16 . Proponents argue improved analgesia versus respiratory depression, itch and nausea for intrathecal opioid, infection risk for epidural infusion and non-union for nonsteriodal anti-inflammatory drugs. To date, publications are small-scale, mostly anecdotal or with short duration follow-up, provoking thoughts for future analgesic studies in scoliosis surgery.
Well-recognised risks of scoliosis surgery are major blood loss and high transfusion requirements 17, 18 ; interventions to minimise blood loss varied between institutions influenced by varying efficacies, safety and cost considerations. The techniques employed were similar to those previously reported in 2003 1 , except for less preoperative autologous donation in paediatric scoliosis surgery.
Combining available blood-sparing techniques synergistically reduces allogenic transfusion requirements 19 . The frequencies of reported use (in 2003 and currently) suggests co-employment is likely but combination or stratification of use was not addressed. Paediatric scoliosis anaesthetists frequently employ CH; the preferred pharmacological agent to achieve this is now IV remifentanil infusion. Previously a MAP of 65 to 70 mmHg was specified for scoliosis surgery 7, 20 . In the current survey, anaesthetists had a lower target MAP during CH. Only one quarter of anaesthetists defined what they believed to be a 'safe or acceptable' MAP during scoliosis surgery and this was similar to that specified during the use of CH. Possibly the increased NPM use permits tolerance of a lower MAP (to minimise blood loss) with the response of elevation of MAP in the event of NPM change. Cell-saver use is high, although its efficacy is supported only when large blood loss transpires 21 . A cost-benefit analysis suggested cell-saver use is efficacious but not warranted routinely in shortsegment adult lumbar fusion surgery 22 . Its expense (capital outlay, ongoing maintenance, disposables and additional staffing) is a fraction of the surgical instrumentation's cost, explaining the surveyed and North American scoliosis centres' practice.
The previous North American survey reported no antifibrinolytic use 1 , while the surveyed institutions and North American paediatric scoliosis centres (personal communication: pac@anaes.sickkids. on.ca) use them widely. No direct comparative trial exists to support the greater IV aprotinin use over TXA. Placebo-controlled studies support equal effectiveness in allogenic transfusion reduction 19, 23 and IV TXA is cheaper, without aprotinin's anaphylaxis risk, renal and thrombotic side-effects 24 or association with higher mortality in adult cardiac surgery 25 . It is unknown if these latter complications translate to paediatric surgery. In any event, aprotinin is no longer marketed. Study of IV antifibrinolytic use in scoliosis surgery is required to affirm optimal dosing 19 particularly with the 10-fold difference in TXA protocols 2 and its suggested dose-dependent effect 19 .
Permanent neurological injury is an infrequent (<2%), but an acknowledged scoliosis surgical risk 26, 27 . Surveyed institutions use several electro-NPM techniques over wake-up testing as they allow 'real-time' monitoring reducing delay in surgical corrective response. Epidural SEP monitoring is widely used. It is both easily interrupted and reproduced and has supplanted cortical SEP monitoring (which is highly influenced by anaesthetic agents). SEP monitoring alone provides high-level prediction of sensory and mixed deficits 28 occurring with 'global' neurological insult (i.e. involving anterior and posterior cord as occurs with cord distraction or spinal arterial compromise).
Epidural MEP monitoring, initially recording from peripheral nerves (termed neurogenic) and then recording motor action potentials (called myogenic MEP or CMAP monitoring), and most recently transcranial MEP monitoring have been increasingly adopted with the advantage of shorter stimulus to assessment and surgical/anaesthetic response time. They are superior to both types of SEP monitoring 8, 28, 30 by providing early warning of spinal cord compromise through progressive D-wave and/or CMAP amplitude reduction 28 and positively predict postoperative outcome 100% 7, 8, 27, 29, 30 . The surveyed NPM use is similar to a 2002 American NPM societal survey 31 . Neither the current nor the American NPM societal survey addressed frequency of combination use, which increases the sensitivity and specificity, although false negatives and positives occur with all techniques 7, 8, 28, 32 . Additionally, the newer NPM techniques are costly and require neurophysiologist staffing and training. The optimal anaesthetic type is not established, as studies to date [6] [7] [8] are not adequately powered to assess impact on adverse neurological outcomes. Large-scale publications are required to enable justification of the costs of the newer NPM systems and employment of neurophysiologists to institutional review boards and theatre management and hospital financiers.
This survey was directed at anaesthetists with a subspecialty interest in paediatric scoliosis surgery. Their report of usual practice is likely to be accurate, but that of rare adverse events is limited by recall and reporting bias. Large-scale audit more reliably establishes complication incidence 26, 27, 33 and may permit risk factor sub-analysis. Recent North American adolescent idiopathic scoliosis audits present negative outcome data from voluntary surgical reporting (n=6344 27 ) and prospective multi-centre audit (n=702 33 ; n=1301 26 ). Two report neurological complications that are mostly spinal cord (57%) with the majority recovering completely (61 to 100%) 26, 27 . Non-neurological complications (pulmonary, bleeding, wound or implant infection, fusion failure and reoperation) are infrequent (0.14 to 3.5%) and deaths were rare (0.04%) 27 . Sub-analysis showed that complications increased with combined surgery 27 , high blood loss, prolonged operative times and renal disease 33 . These audits provide data about low-risk scoliosis patients, while the current survey presents major recalled negative outcomes, such as neurological morbidity and mortality, in a mixed scoliosis population. Approaching the respondents to provide more detailed information on individual patients and their anaesthetic and surgical management would be useful, as would combining the information as a case series.
In this survey, even when a common theme was identified such as remifentanil infusion or antifibrinolytic use, the range of agent administered widely differs. As suggested, more study is required to provide an evidence base to support best anaesthetic and monitoring practices to reduce the rare but serious morbidity associated with this subspecialty surgery. One example is to establish whether there is a combination of NPM that is optimal, such as combined epidural SEP/transcranial MEP/CMAP use, and another is to determine whether a TIVA propofol-remifentanil-ketamine based anaesthetic affects the neurophysiological readings less than other anaesthetic techniques.
In conclusion, the results from surveying multiple (generally subspecialist paediatric) centres in four countries indicate that there is wide variation regarding both anaesthetic and surgical practices for paediatric scoliosis surgery. The information obtained may suggest new strategies to various centres, and could be useful for planning multi-centre audits and trials.
